Healios, Athersys Confident Despite Missed Japan Stroke Endpoint

Investors Much Less Upbeat

stroke patient
Missed stroke endpoint for Healios' cell therapy • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia